Memphis Pharmaceuticals (MPCI.CA) - The Central Auditing Organization's Report
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Central Auditing Organization's report on the financial statements for the financial period ending 31/03/2026
The Central Auditing Organization's Report (1,013 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Central Auditing Organization's report on the financial statements for the financial period ending 31/03/2026
The Central Auditing Organization's Report (1,013 KB)
Comments